AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Daniel, L Durbec, P Gautherot, E Rouvier, E Rougon, G Figarella-Branger, D
Citation: L. Daniel et al., A nude mice model of human rhabdomyosarcoma lung metastases for evaluatingthe role of polysialic acids in the metastatic process, ONCOGENE, 20(8), 2001, pp. 997-1004

Authors: de Labriolle-Vaylet, C Cattan, P Sarfati, E Wioland, M Billotey, C Brocheriou, C Rouvier, E de Roquancourt, A Rostene, W Askienazy, S Barbet, J Milhaud, G Gruaz-Guyon, A
Citation: C. De Labriolle-vaylet et al., Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery, CLIN CANC R, 6(2), 2000, pp. 363-371

Authors: Gautherot, E Rouvier, E Daniel, L Loucif, E Bouhou, J Manetti, C Martin, M Le Doussal, JM Barbet, J
Citation: E. Gautherot et al., Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and I-131-labeled bivalent hapten, J NUCL MED, 41(3), 2000, pp. 480-487

Authors: Gautherot, E Kraeber-Bodere, F Daniel, L Fiche, M Rouvier, E Sai-Maurel, C Thedrez, P Chatal, JF Barbet, J
Citation: E. Gautherot et al., Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody, CLIN CANC R, 5(10), 1999, pp. 3177S-3182S

Authors: Kraeber-Bodere, F Bardet, S Hoefnagel, CA Vieira, MR Vuillez, JP Murat, A Ferreira, TC Bardies, M Ferrer, L Resche, I Gautherot, E Rouvier, E Barbet, J Chatal, JF
Citation: F. Kraeber-bodere et al., Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial, CLIN CANC R, 5(10), 1999, pp. 3190S-3198S

Authors: Vuillez, JP Kraeber-Bodere, F Moro, D Bardies, M Douillard, JY Gautherot, E Rouvier, E Barbet, J Garban, F Moreau, P Chatal, JF
Citation: Jp. Vuillez et al., Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial, CLIN CANC R, 5(10), 1999, pp. 3259S-3267S
Risultati: 1-6 |